Flagship Biosciences Expands Tissue Image Analysis Capabilities at New Colorado Location in Support of Pharmaceutical and Clinical Clients
Summary
Flagship Biosciences, the leader in data-centric pathology and tissue analysis, today announced that the company has moved its headquarters to a new location in Broomfield, Colorado, just north of Denver. “Flagship’s core strengths are in performing artificial intelligence enhanced tissue analysis to help pathologists do their work more quickly and efficiently, enabling them to identify the patients who will benefit most from a therapeutic. Our new laboratory setup and additional space will empower our teams to continue to collaborate and as we revolutionize tissue analysis to improve drug development and diagnostics.” Flagship’s technology, scientific process, and pathology oversight enable their clients to rapidly identify the right patients for clinical trials, and its regulatory experts provide guidance for biomarker development from early discovery through commercialization. The company’s image analysis capabilities also provide a superior return on investment as clients save time in bringing their drugs to market. Founded in 2009 and headquartered in Broomfield, Colorado, Flagship Biosciences, Inc. is a technology-driven tissue analysis services company delivering the most accurate and informative data available.